NFE2L3 (Nuclear Factor Erythroid 2-Like 3), also known as Nrf3, is a transcription factor belonging to the Cap'n'collar (CNC) family of basic leucine zipper proteins. While historically less studied than its well-known paralog NFE2L2 (Nrf2), emerging research suggests NFE2L3 plays important roles in cellular stress responses, oxidative stress defense, and may have relevance to neurodegenerative disease pathogenesis. The NFE2L3 gene encodes a protein that heterodimerizes with small Maf proteins to regulate antioxidant response element (ARE)-driven gene expression[1].
| Nuclear Factor Erythroid 2-Like 3 Protein | |
|---|---|
| Protein Name | Nuclear Factor Erythroid 2-Like 3 Protein |
| Gene Symbol | [NFE2L3](/genes/nfe2l3) |
| UniProt ID | [Q9Y5U8](https://www.uniprot.org/uniprot/Q9Y5U8) |
| Alternative Names | Nrf3, NFE2L3 |
| Molecular Weight | ~65-90 kDa |
| Subcellular Location | Nucleus (ER-anchored precursor) |
| Protein Family | CNC (Cap'n'collar) bZIP family |
The CNC family of transcription factors, which includes NFE2L1, NFE2L2, and NFE2L3, regulates cellular defense mechanisms against oxidative and electrophilic stress. NFE2L3 was initially characterized as a placental-specific factor but subsequent studies revealed broader expression patterns, including in the brain[2]. Unlike NFE2L2, which is the master regulator of the antioxidant response and has extensively studied roles in Alzheimer's disease and Parkinson's disease, NFE2L3's functions in neurodegeneration remain an emerging area of research.
NFE2L3 protein contains several conserved domains characteristic of the CNC family:
The protein is initially synthesized as an endoplasmic reticulum (ER)-anchored precursor. Following proteolytic processing, the active form translocates to the nucleus where it can bind to Antioxidant Response Elements (AREs) in the promoters of target genes[3].
NFE2L3 undergoes several post-translational modifications that regulate its activity:
NFE2L3 functions as a transcriptional activator by forming heterodimers with small Maf proteins. These complexes bind to Antioxidant Response Elements (ARE sequences, 5'-TGACnnnGC-3') in the promoter regions of target genes[4]. Key target genes include:
NFE2L3 is expressed in various brain regions, including:
Expression is detected in both neurons and glial cells (astrocytes and microglia), though at lower levels than NFE2L2[5].
NFE2L3 expression is regulated by:
| Partner Protein | Interaction Type | Functional Significance |
|---|---|---|
| MAFF | Heterodimer | DNA binding to ARE sequences |
| MAFG | Heterodimer | DNA binding, transcriptional activation |
| MAFK | Heterodimer | Transcriptional repression/dimerization |
| KEAP1 | Potential interaction | Potential redox regulation (similar to Nrf2) |
| CBP/p300 | Co-activator recruitment | Transcriptional activation |
NFE2L3 participates in several cellular signaling pathways:
While research on NFE2L3 in neurodegeneration is less extensive than for NFE2L2, several connections have been identified:
NFE2L3 has been more extensively studied in cancer biology, where it can function as both tumor suppressor and oncogenic factor depending on context. This dual role highlights the complexity of NFE2L3 signaling.
While no NFE2L3-specific therapeutics exist yet, several strategies are being explored:
NFE2L3 (Nrf3) is an emerging player in cellular stress responses with growing relevance to neurodegenerative diseases. While less characterized than NFE2L2, NFE2L3 contributes to antioxidant defense, protein homeostasis, and cellular protection mechanisms in the brain. Future research will clarify its specific roles in Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions, potentially revealing new therapeutic targets for enhancing neuroprotection.
Zhang & Tian (2023) NFE2L3/Nrf3: An underrated transcription factor in oxidative stress and cancer. Free Radical Biology & Medicine. 2023. ↩︎
Kobayashi et al. (2019) Nrf3 in the protection of the brain. Journal of Neuroscience Research. 2019. ↩︎
Nightingale et al. (2022) The proteolytic processing of NFE2L3. Cellular and Molecular Life Sciences. 2022. ↩︎
Sykiotis & Bohmann (2010) Stress-activated cap'n'collar transcription factors in aging and human disease. Science Signaling. 2010. ↩︎
Ramachandran et al. (2021) Nrf3 in the central nervous system. Antioxidants & Redox Signaling. 2021. ↩︎
Jadeja et al. (2019) Nrf2 and Nrf3 in Alzheimer's disease. Journal of Alzheimer's Disease. 2019. ↩︎